Logo image of SOLV.BR

SOLVAC SA-REG (SOLV.BR) Stock Fundamental Analysis

EBR:SOLV - Euronext Brussels - BE0003545531 - Common Stock - Currency: EUR

88.4  +0.4 (+0.45%)

Fundamental Rating

4

Overall SOLV gets a fundamental rating of 4 out of 10. We evaluated SOLV against 67 industry peers in the Chemicals industry. SOLV has an average financial health and profitability rating. SOLV has a valuation in line with the averages, but on the other hand it scores bad on growth. SOLV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year SOLV was profitable.
In the past year SOLV has reported a negative cash flow from operations.
Of the past 5 years SOLV 4 years were profitable.
In multiple years SOLV reported negative operating cash flow during the last 5 years.
SOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLV.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 3.83%, SOLV is in the better half of the industry, outperforming 65.67% of the companies in the same industry.
With a Return On Equity value of 4.16%, SOLV perfoms like the industry average, outperforming 58.21% of the companies in the same industry.
With a Return On Invested Capital value of 3.11%, SOLV perfoms like the industry average, outperforming 53.73% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SOLV is below the industry average of 6.51%.
Industry RankSector Rank
ROA 3.83%
ROE 4.16%
ROIC 3.11%
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
SOLV.BR Yearly ROA, ROE, ROICSOLV.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

With an excellent Profit Margin value of 94.15%, SOLV belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
SOLV's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 97.72%, SOLV belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Operating Margin of SOLV has grown nicely.
Industry RankSector Rank
OM 97.72%
PM (TTM) 94.15%
GM N/A
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
SOLV.BR Yearly Profit, Operating, Gross MarginsSOLV.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100 200 300 400

More info and screens

4

2. Health

2.1 Basic Checks

Compared to 1 year ago, SOLV has about the same amount of shares outstanding.
The number of shares outstanding for SOLV remains at a similar level compared to 5 years ago.
The debt/assets ratio for SOLV has been reduced compared to a year ago.
SOLV.BR Yearly Shares OutstandingSOLV.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SOLV.BR Yearly Total Debt VS Total AssetsSOLV.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

SOLV has an Altman-Z score of 6.36. This indicates that SOLV is financially healthy and has little risk of bankruptcy at the moment.
SOLV has a Altman-Z score of 6.36. This is amongst the best in the industry. SOLV outperforms 92.54% of its industry peers.
SOLV has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.04, SOLV belongs to the best of the industry, outperforming 91.04% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 6.36
ROIC/WACCN/A
WACCN/A
SOLV.BR Yearly LT Debt VS Equity VS FCFSOLV.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

SOLV has a Current Ratio of 0.30. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.30, SOLV is not doing good in the industry: 94.03% of the companies in the same industry are doing better.
SOLV has a Quick Ratio of 0.30. This is a bad value and indicates that SOLV is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.30, SOLV is not doing good in the industry: 92.54% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.3
SOLV.BR Yearly Current Assets VS Current LiabilitesSOLV.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for SOLV have decreased strongly by -49.60% in the last year.
The Earnings Per Share has been growing by 26.70% on average over the past years. This is a very strong growth
SOLV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -48.83%.
Measured over the past years, SOLV shows a very strong growth in Revenue. The Revenue has been growing by 24.62% on average per year.
EPS 1Y (TTM)-49.6%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%-77.45%
Revenue 1Y (TTM)-48.83%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%-76.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SOLV.BR Yearly Revenue VS EstimatesSOLV.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B
SOLV.BR Yearly EPS VS EstimatesSOLV.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 5 10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 18.04 indicates a rather expensive valuation of SOLV.
Compared to the rest of the industry, the Price/Earnings ratio of SOLV indicates a somewhat cheap valuation: SOLV is cheaper than 68.66% of the companies listed in the same industry.
SOLV's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.45.
Based on the Price/Forward Earnings ratio of 6.09, the valuation of SOLV can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SOLV indicates a rather cheap valuation: SOLV is cheaper than 100.00% of the companies listed in the same industry.
SOLV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 18.04
Fwd PE 6.09
SOLV.BR Price Earnings VS Forward Price EarningsSOLV.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SOLV.BR Per share dataSOLV.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.71
PEG (5Y)0.68
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

7

5. Dividend

5.1 Amount

SOLV has a Yearly Dividend Yield of 4.67%, which is a nice return.
Compared to an average industry Dividend Yield of 3.08, SOLV pays a better dividend. On top of this SOLV pays more dividend than 83.58% of the companies listed in the same industry.
SOLV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.42.
Industry RankSector Rank
Dividend Yield 4.67%

5.2 History

The dividend of SOLV has a limited annual growth rate of 1.34%.
Dividend Growth(5Y)1.34%
Div Incr Years0
Div Non Decr Years0
SOLV.BR Yearly Dividends per shareSOLV.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

SOLV pays out 118.44% of its income as dividend. This is not a sustainable payout ratio.
SOLV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP118.44%
EPS Next 2YN/A
EPS Next 3YN/A
SOLV.BR Yearly Income VS Free CF VS DividendSOLV.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
SOLV.BR Dividend Payout.SOLV.BR Dividend Payout, showing the Payout Ratio.SOLV.BR Dividend Payout.PayoutRetained Earnings

More info and screens

SOLVAC SA-REG

EBR:SOLV (7/3/2025, 7:00:00 PM)

88.4

+0.4 (+0.45%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-07 2025-03-07
Earnings (Next)07-30 2025-07-30
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners5.24%
Ins Owner ChangeN/A
Market Cap1.89B
Analysts42.22
Price Target152.75 (72.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.67%
Yearly Dividend5.8
Dividend Growth(5Y)1.34%
DP118.44%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.04
Fwd PE 6.09
P/S 17
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)4.9
EY5.54%
EPS(NY)14.52
Fwd EY16.43%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)-0.14
OCFYN/A
SpS5.2
BVpS117.7
TBVpS117.7
PEG (NY)2.71
PEG (5Y)0.68
Profitability
Industry RankSector Rank
ROA 3.83%
ROE 4.16%
ROCE 4.15%
ROIC 3.11%
ROICexc 3.12%
ROICexgc 3.12%
OM 97.72%
PM (TTM) 94.15%
GM N/A
FCFM N/A
ROA(3y)4.3%
ROA(5y)2.1%
ROE(3y)4.67%
ROE(5y)2.26%
ROIC(3y)3.44%
ROIC(5y)N/A
ROICexc(3y)3.44%
ROICexc(5y)N/A
ROICexgc(3y)3.61%
ROICexgc(5y)N/A
ROCE(3y)4.58%
ROCE(5y)N/A
ROICexcg growth 3Y-27.07%
ROICexcg growth 5Y31.12%
ROICexc growth 3Y-24.14%
ROICexc growth 5Y34%
OM growth 3Y-0.21%
OM growth 5Y2.47%
PM growth 3Y-1.44%
PM growth 5Y1.71%
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.3
Altman-Z 6.36
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-49.6%
EPS 3Y-29.04%
EPS 5Y26.7%
EPS Q2Q%-77.45%
EPS Next Y6.67%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-48.83%
Revenue growth 3Y-28%
Revenue growth 5Y24.62%
Sales Q2Q%-76.43%
Revenue Next Year3.68%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-49.22%
EBIT growth 3Y-28.15%
EBIT growth 5Y27.7%
EBIT Next Year44.79%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.44%
OCF growth 3YN/A
OCF growth 5YN/A